PFE registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Oct 24, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Oct 24, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | Apr 21, 2034 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | Apr 21, 2034 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | Apr 12, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | Apr 12, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Jul 1, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Oct 20, 2026 (actual) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Oct 20, 2026 (actual) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Completed | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Dec 31, 2026 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Oct 31, 2025 (actual) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Oct 30, 2026 (actual) | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETResults postedNCT05348915A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseasePFE
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Oct 24, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion date
- Now
- Oct 24, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETResults posted
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07932925A Study to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight (VESPER-SUI)PFE
- Now
- Recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT07839884A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of...PFE
- Now
- Apr 21, 2034 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion dateNCT07839884A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of...PFE
- Now
- Apr 21, 2034 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT07839884A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of...PFE
- Now
- Recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT07897669A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different...PFE
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion date
- Now
- Apr 12, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion date
- Now
- Apr 12, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT06629779A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.PFE
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT07859527A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or BPFE
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT06398626An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisPFE
- Now
- Jul 1, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT06398626An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisPFE
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion date
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion date
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion date
- Now
- Dec 31, 2026 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion date
- Now
- Oct 31, 2025 (actual)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatusNCT05253651A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerPFE
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT03774901Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaPFE
- Now
- Oct 30, 2026 (actual)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 changes. There are 15 more in this window; the full list is part of TrialScanner.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.